Concourse Financial Group Securities’s GoodRx Holdings GDRX Stock Holding History

Concourse Financial Group Securities’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400	Closed	-$1.88K	–	821
2024 Q4	$1.88K	Sell	400 -300	-43%	-$1.65K	﹤0.01%	2024
2024 Q3	$4.86K	Hold	700	–	–	﹤0.01%	1867
2024 Q2	$5.46K	Hold	700	–	–	﹤0.01%	1852
2024 Q1	$4.97K	Buy	700 +200	+40%	+$1.32K	﹤0.01%	1882
2023 Q4	$3.35K	Hold	500	–	–	﹤0.01%	1935
2023 Q3	$2.81K	Hold	500	–	–	﹤0.01%	1943
2023 Q2	$2.76K	Hold	500	–	–	﹤0.01%	1964
2023 Q1	$3.13K	Sell	500 -200	-29%	-$1.11K	﹤0.01%	1974
2022 Q4	$3.26K	Hold	700	–	–	﹤0.01%	1950
2022 Q3	$3K	Sell	700 -200	-22%	-$1.26K	﹤0.01%	1740
2022 Q2	$5K	Hold	900	–	–	﹤0.01%	1836
2022 Q1	$17K	Buy	+900	New	+$20.6K	﹤0.01%	1538

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

Concourse Financial Group Securities's GDRX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 400 shares — an estimated $1.88K sold.

Concourse Financial Group Securities first reported a position in GDRX in Q1 2022 and held it in 12 quarters. The position peaked at $17K in Q1 2022. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

Concourse Financial Group Securities reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 400 GoodRx Holdings shares in Q1 2025, an estimated $1.88K.
Concourse Financial Group Securities first reported a position in GoodRx Holdings in Q1 2022 and held it in 12 quarters.
Concourse Financial Group Securities's GoodRx Holdings position peaked at $17K in Q1 2022.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.